Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 8 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HNX4
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 10 |
GO:0006629 | lipid metabolic process | 3 | 10 |
GO:0006631 | fatty acid metabolic process | 4 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0019752 | carboxylic acid metabolic process | 5 | 10 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 10 |
GO:0043436 | oxoacid metabolic process | 4 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0044255 | cellular lipid metabolic process | 3 | 10 |
GO:0044281 | small molecule metabolic process | 2 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0006635 | fatty acid beta-oxidation | 6 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009062 | fatty acid catabolic process | 5 | 1 |
GO:0016042 | lipid catabolic process | 4 | 1 |
GO:0016054 | organic acid catabolic process | 4 | 1 |
GO:0019395 | fatty acid oxidation | 5 | 1 |
GO:0030258 | lipid modification | 4 | 1 |
GO:0034440 | lipid oxidation | 5 | 1 |
GO:0044242 | cellular lipid catabolic process | 4 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044282 | small molecule catabolic process | 3 | 1 |
GO:0046395 | carboxylic acid catabolic process | 5 | 1 |
GO:0072329 | monocarboxylic acid catabolic process | 6 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 10 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity | 5 | 6 |
GO:0005488 | binding | 1 | 10 |
GO:0016491 | oxidoreductase activity | 2 | 10 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 10 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 10 |
GO:0036094 | small molecule binding | 2 | 10 |
GO:0043167 | ion binding | 2 | 10 |
GO:0043168 | anion binding | 3 | 10 |
GO:0051287 | NAD binding | 4 | 10 |
GO:0070403 | NAD+ binding | 4 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901265 | nucleoside phosphate binding | 3 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 105 | 109 | PF00656 | 0.239 |
CLV_C14_Caspase3-7 | 243 | 247 | PF00656 | 0.253 |
CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.308 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.335 |
CLV_Separin_Metazoa | 165 | 169 | PF03568 | 0.424 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.579 |
DOC_CYCLIN_RxL_1 | 108 | 118 | PF00134 | 0.424 |
DOC_CYCLIN_yCln2_LP_2 | 205 | 211 | PF00134 | 0.308 |
DOC_MAPK_gen_1 | 145 | 154 | PF00069 | 0.308 |
DOC_MAPK_gen_1 | 185 | 192 | PF00069 | 0.424 |
DOC_MAPK_RevD_3 | 96 | 111 | PF00069 | 0.424 |
DOC_MIT_MIM_1 | 112 | 120 | PF04212 | 0.226 |
DOC_PP2B_LxvP_1 | 205 | 208 | PF13499 | 0.308 |
DOC_PP4_FxxP_1 | 154 | 157 | PF00568 | 0.308 |
DOC_USP7_UBL2_3 | 185 | 189 | PF12436 | 0.367 |
DOC_USP7_UBL2_3 | 284 | 288 | PF12436 | 0.308 |
DOC_USP7_UBL2_3 | 295 | 299 | PF12436 | 0.426 |
DOC_WW_Pin1_4 | 153 | 158 | PF00397 | 0.308 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.339 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.473 |
DOC_WW_Pin1_4 | 270 | 275 | PF00397 | 0.383 |
LIG_14-3-3_CanoR_1 | 123 | 127 | PF00244 | 0.288 |
LIG_14-3-3_CanoR_1 | 219 | 225 | PF00244 | 0.367 |
LIG_BRCT_BRCA1_1 | 123 | 127 | PF00533 | 0.424 |
LIG_BRCT_BRCA1_1 | 6 | 10 | PF00533 | 0.492 |
LIG_EH1_1 | 199 | 207 | PF00400 | 0.308 |
LIG_eIF4E_1 | 264 | 270 | PF01652 | 0.448 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.300 |
LIG_FHA_1 | 167 | 173 | PF00498 | 0.424 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.362 |
LIG_FHA_2 | 221 | 227 | PF00498 | 0.332 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.308 |
LIG_FHA_2 | 72 | 78 | PF00498 | 0.333 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.295 |
LIG_LIR_Gen_1 | 112 | 122 | PF02991 | 0.303 |
LIG_LIR_Gen_1 | 223 | 231 | PF02991 | 0.403 |
LIG_LIR_Gen_1 | 258 | 268 | PF02991 | 0.299 |
LIG_LIR_Nem_3 | 112 | 117 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 146 | 152 | PF02991 | 0.240 |
LIG_LIR_Nem_3 | 223 | 227 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 291 | 296 | PF02991 | 0.308 |
LIG_LIR_Nem_3 | 7 | 13 | PF02991 | 0.512 |
LIG_Pex14_1 | 260 | 264 | PF04695 | 0.383 |
LIG_SH3_3 | 235 | 241 | PF00018 | 0.308 |
LIG_SH3_3 | 262 | 268 | PF00018 | 0.308 |
LIG_SUMO_SIM_par_1 | 34 | 40 | PF11976 | 0.317 |
LIG_UBA3_1 | 113 | 119 | PF00899 | 0.367 |
LIG_UBA3_1 | 57 | 64 | PF00899 | 0.383 |
LIG_WRC_WIRS_1 | 221 | 226 | PF05994 | 0.424 |
LIG_WRC_WIRS_1 | 72 | 77 | PF05994 | 0.362 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.317 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.383 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.308 |
MOD_CK2_1 | 132 | 138 | PF00069 | 0.406 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.226 |
MOD_CK2_1 | 34 | 40 | PF00069 | 0.367 |
MOD_CK2_1 | 83 | 89 | PF00069 | 0.308 |
MOD_Cter_Amidation | 285 | 288 | PF01082 | 0.308 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.623 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.327 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.321 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.454 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.289 |
MOD_N-GLC_1 | 129 | 134 | PF02516 | 0.308 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.308 |
MOD_NEK2_1 | 46 | 51 | PF00069 | 0.332 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.383 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.391 |
MOD_NEK2_2 | 122 | 127 | PF00069 | 0.424 |
MOD_PKA_2 | 122 | 128 | PF00069 | 0.241 |
MOD_Plk_1 | 129 | 135 | PF00069 | 0.308 |
MOD_Plk_1 | 53 | 59 | PF00069 | 0.308 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.392 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.308 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.308 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.262 |
MOD_ProDKin_1 | 153 | 159 | PF00069 | 0.308 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.339 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.465 |
MOD_ProDKin_1 | 270 | 276 | PF00069 | 0.383 |
MOD_SUMO_for_1 | 109 | 112 | PF00179 | 0.424 |
MOD_SUMO_for_1 | 172 | 175 | PF00179 | 0.271 |
MOD_SUMO_rev_2 | 165 | 174 | PF00179 | 0.303 |
MOD_SUMO_rev_2 | 66 | 72 | PF00179 | 0.260 |
TRG_DiLeu_BaEn_1 | 212 | 217 | PF01217 | 0.332 |
TRG_DiLeu_BaLyEn_6 | 201 | 206 | PF01217 | 0.308 |
TRG_DiLeu_BaLyEn_6 | 271 | 276 | PF01217 | 0.383 |
TRG_NES_CRM1_1 | 246 | 258 | PF08389 | 0.226 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKX2 | Leptomonas seymouri | 74% | 100% |
A0A0S4JB86 | Bodo saltans | 61% | 100% |
A0A1X0P8Y1 | Trypanosomatidae | 60% | 100% |
A0A3Q8IQN1 | Leishmania donovani | 88% | 100% |
A4ICM0 | Leishmania infantum | 87% | 100% |
B1VLT7 | Streptomyces griseus subsp. griseus (strain JCM 4626 / NBRC 13350) | 29% | 91% |
D7URM0 | Pseudomonas sp. | 28% | 95% |
E9ASN4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
P00348 | Sus scrofa | 55% | 97% |
P14755 | Oryctolagus cuniculus | 28% | 96% |
P34439 | Caenorhabditis elegans | 46% | 100% |
P41938 | Caenorhabditis elegans | 52% | 99% |
P45364 | Clostridioides difficile | 38% | 100% |
P45856 | Bacillus subtilis (strain 168) | 41% | 100% |
P52041 | Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) | 39% | 100% |
P77851 | Thermoanaerobacterium thermosaccharolyticum (strain ATCC 7956 / DSM 571 / NCIMB 9385 / NCA 3814 / NCTC 13789 / WDCM 00135 / 2032) | 41% | 100% |
P83589 | Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422) | 29% | 88% |
P9WNP6 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 42% | 100% |
P9WNP7 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 42% | 100% |
Q0AVM2 | Syntrophomonas wolfei subsp. wolfei (strain DSM 2245B / Goettingen) | 40% | 100% |
Q16836 | Homo sapiens | 55% | 97% |
Q45223 | Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) | 38% | 100% |
Q4Q1W2 | Leishmania major | 86% | 100% |
Q4V182 | Bacillus cereus (strain ZK / E33L) | 28% | 94% |
Q5RDZ2 | Pongo abelii | 28% | 96% |
Q61425 | Mus musculus | 56% | 97% |
Q811X6 | Rattus norvegicus | 27% | 96% |
Q88R32 | Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440) | 30% | 95% |
Q8SPX7 | Bos taurus | 27% | 95% |
Q8SQ26 | Sus scrofa | 28% | 95% |
Q93RX5 | Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) | 28% | 96% |
Q988C8 | Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) | 30% | 99% |
Q99KP3 | Mus musculus | 28% | 96% |
Q9RVG1 | Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422) | 41% | 100% |
Q9WVK7 | Rattus norvegicus | 56% | 97% |
Q9Y2S2 | Homo sapiens | 28% | 96% |
V5BPS0 | Trypanosoma cruzi | 63% | 95% |
W7MSH6 | Gibberella moniliformis (strain M3125 / FGSC 7600) | 27% | 95% |